From large institutional investors to smaller quantitative investors, proxy voting guidelines increasingly reference ESG issues such as board diversity and climate change, requiring companies to meet a minimum ESG performance threshold for investors to vote in accord with management.
In this latest edition of Stern IR’s “ESG In Focus” series, we leverage proprietary data on a large number of investors in the healthcare and biotech space to assess their level of engagement around ESG and how ESG factors into their approach to proxy voting.
